Eléments de l'association

	Essai clinique phase II	24
	A. M. Traynor	1
	Essai clinique phase II *Sauf* A. M. Traynor"	23
	A. M. Traynor *Sauf* Essai clinique phase II"	0
	Essai clinique phase II Et A. M. Traynor	1
	Essai clinique phase II Ou A. M. Traynor	24
	*Corpus*	7667

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000A05	J. R. Brahmer [États-Unis] ; J. W. Lee [États-Unis] ; A. M. Traynor [États-Unis] ; M. M. Hidalgo [Espagne] ; J. M. Kolesar [États-Unis] ; J. M. Siegfried [États-Unis] ; P. P. Guaglianone [États-Unis] ; J. D. Patel [États-Unis] ; M. D. Keppen [États-Unis] ; J. H. Schiller [États-Unis]	Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021